🇺🇸 FDA
Patent

US 9994566

Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof

granted A61KA61K31/4375A61K31/444

Quick answer

US patent 9994566 (Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof) held by Shenyang Sunshine Pharmaceutical Co., LTD expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Shenyang Sunshine Pharmaceutical Co., LTD
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/4375, A61K31/444, A61P, A61P1/00